As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:
Dr. Ettinger reports receiving a consulting fee from BeyondSpring Inc., Boehringer Ingelheim Vetmedica GmbH, Bristol-Myers Squib Company, Eli Lilly and Company, Guardant Health, Inc., Genentech, Inc., and sanofi-aventis
Dr Gojo reports serving as a principal investigator for Amgen, Inc, Amphivena Therapeutics, Inc., and Merck & Co, Inc; and reports that her spouse serves as a principal investigator for Genentech, Inc.
No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with any commercial interest.
Note: Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution that receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).